Idiopathic thrombocytopenic purpura and the drug abciximab both target platelet membrane glycoprotein IIb-IIIa. ITP is an immune destruction of platelets. Besides being impossible to pronounce, abciximab is used in patients undergoing percutaneous coronary intervention, and is an antiplatelet agent.
I Finally Figured Out What Productivity Hack Helps Me Crush My New Year's
Resolutions
-
I tried a little something new last year—and it worked.
1 hour ago
Posts
quick question, doesnt idiopathic mean we dont know whats causing the dz? How can this be idiopathic, if we know its due to immune destruction?
ReplyDelete